reference/4485462

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4485462

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	851
issn	0306-5251 1365-2125
issueIdentifier	6
pageRange	844-851
publicationName	British Journal of Clinical Pharmacology
startingPage	844
bibliographicCitation	Lesault P, Boyer L, Pelle G, Covali‐Noroc A, Rideau D, Akakpo S, Teiger E, Dubois‐Randé J, Adnot S. Daily administration of the TP receptor antagonist terutroban improved endothelial function in high‐cardiovascular‐risk patients with atherosclerosis. Brit J Clinical Pharma. 2011 May 12;71(6):844–51. doi: 10.1111/j.1365-2125.2010.03858.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1d9f2b25c2262a823ef1ed7d4d47ff3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8d6a016b14326cafc2dde4133d234ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38937c69eb23884b3a4447fc8f028ab2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7f2db018c3aa37f92bd2e5a37c2c8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08b7e13592587eee8b931279ce7cf86b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9afc7a0e4f52227b02f730cbd099e986 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_602222b59883f8e2c2d253b17935a442 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b69f2938ca685b91a89b3060e0701529 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fbd54aeac5a2bf1462bb7b912f1427c
date	2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21564160 https://doi.org/10.1111/j.1365-2125.2010.03858.x https://pubmed.ncbi.nlm.nih.gov/PMC3099371
isPartOf	https://portal.issn.org/resource/ISSN/0306-5251 https://portal.issn.org/resource/ISSN/1365-2125 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1743
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Daily administration of the TP receptor antagonist terutroban improved endothelial function in high‐cardiovascular‐risk patients with atherosclerosis
discusses	http://id.nlm.nih.gov/mesh/M0026518 http://id.nlm.nih.gov/mesh/M0290640 http://id.nlm.nih.gov/mesh/M0017759 http://id.nlm.nih.gov/mesh/M0014459
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D050197Q000188 http://id.nlm.nih.gov/mesh/D003324Q000517 http://id.nlm.nih.gov/mesh/D004730Q000187 http://id.nlm.nih.gov/mesh/D017482Q000037 http://id.nlm.nih.gov/mesh/D011422Q000008 http://id.nlm.nih.gov/mesh/D009281Q000008 http://id.nlm.nih.gov/mesh/D010974Q000187
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017482Q000008 http://id.nlm.nih.gov/mesh/D009281Q000627 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D011422Q000627 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311493 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7182 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9938840 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6145931

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243806094 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 67.